You are here:
NICE
NICE Guidance
Published Guidance
Certolizumab pegol for the treatment of rheumatoid arthritis
Technology appraisal guidance
Reference number:
TA186
Published:
24 February 2010
This guidance has been updated and replaced by
NICE technology appraisal guidance 375
.